1993
DOI: 10.1056/nejm199312093292403
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Corticosteroids for Acute Optic Neuritis on the Subsequent Development of Multiple Sclerosis

Abstract: In patients with acute optic neuritis, treatment with a three-day course of high-dose intravenous methylprednisolone (followed by a short course of prednisone) reduces the rate of development of multiple sclerosis over a two-year period.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

4
198
0
7

Year Published

1998
1998
2016
2016

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 516 publications
(212 citation statements)
references
References 30 publications
4
198
0
7
Order By: Relevance
“…[1][2][3] Benefit from treatment with intravenous steroid in prevention from multiple sclerosis (MS) has also been extensively analyzed. [4][5][6][7] However, these studies were mostly confined to young adults. Optic neuritis in children is considered to be a totally different entity in contrast to adults.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3] Benefit from treatment with intravenous steroid in prevention from multiple sclerosis (MS) has also been extensively analyzed. [4][5][6][7] However, these studies were mostly confined to young adults. Optic neuritis in children is considered to be a totally different entity in contrast to adults.…”
Section: Introductionmentioning
confidence: 99%
“…Recovery of visual function, visual field testing abnormalities, pain induced by ocular movements, cup-to-disc ratio, presence and/ or distribution of optic disc oedema and fluorescein angiography together which age at diagnosis may help to differentiate optic neuritis (ON) and nonarteritic anterior ischemic optic neuropathy of disc oedema, young age (≤ 35 years), ocular pain associated with eye movements, recovery of visual function in the first month of follow up, no other ocular pathology, no neurological diseases that might influence or explain the patient's visual symptoms; history or detection of multiple sclerosis confirmed the diagnosis [17].…”
Section: Discussionmentioning
confidence: 99%
“…All patients were admitted and received intravenous methylprednisolone (250 mg every 6 h for 3 days) followed by oral prednisolone (1 mg/kg) for 11 days. 15 Patients with any of the following conditions were excluded from the study: a known history of MS or other demyelinating events, bilateral ON, recurrent ON, age < 20 or 465 years, refractive error of < − 6.0 diopters or 4+3.0 diopters (spherical equivalent), media opacities, intracranial lesion or neurologic disorder, systemic medication that may induce optic neuropathy, a history of ocular surgery, and other ocular pathology that may affect OCT measurements including glaucoma and retinal disease. Patients who underwent any treatment before the visit to our clinic and who had a previous history of visual loss or other ocular abnormalities that cause visual loss were also excluded.…”
Section: Diagnosis Of Onmentioning
confidence: 99%